Related Experiment Videos
Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials
1Department of Research, Kantonspital Basel, Switzerland.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pathophysiology of aplastic anaemia.
Blood reviews·1990
Pathophysiology of aplastic anaemia.
Bailliere's clinical haematology·1989
[T-infarct in exercise electrocardiography].
Schweizerische medizinische Wochenschrift·1975
Allogeneic transplantation of peripheral blood progenitor cells.
Nouvelle revue francaise d'hematologie·1995
Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.
Nouvelle revue francaise d'hematologie·1995
Peripheral blood CD34+ cells: method of purification and ex vivo expansion.
Nouvelle revue francaise d'hematologie·1995
Ex vivo expansion of human peripheral blood progenitors.
Nouvelle revue francaise d'hematologie·1995
Expansion of blood CD34 positive cells: committed precursors expansion does not affect immature hematopoietic progenitors.
Nouvelle revue francaise d'hematologie·1995
In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients.
Nouvelle revue francaise d'hematologie·1995
Is it truly patient-centered? Doctor-patient communication in remote programming for Parkinson's disease.
Disability and rehabilitation·2026
Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry.
The Journal of antimicrobial chemotherapy·2026
Cardiac Electrophysiological Impact of Sodium Glucose Cotransporter 2 Inhibitors: A Comprehensive Review.
Circulation. Arrhythmia and electrophysiology·2026
Perioperative Blood Management in General Surgery: Recent Advances, Current Limitations, and the Emerging Role of Artificial Intelligence-A Narrative Review.
International journal of general medicine·2026
Antibody‒cell conjugates: A novel "off-the-shelf" modality bridging ADCs and CAR-T for cancer immunotherapy.
Acta pharmaceutica Sinica. B·2026